Mescaline-assisted therapy software: built for 10–14 hour sessions

Mescaline produces one of the longest psychedelic experiences in clinical use. Ignite Synergy is the operational backbone that makes those sessions safe, structured, and integratable.

Mescaline-assisted therapy sessions can last 10–14 hours from onset to integration handoff. Standard EHRs and scheduling tools weren't designed for that duration, dyad staffing, or the integration arc that follows. Ignite Synergy is.

Mescaline-aware workflows across the full session lifecycle

  • Pre-session screening for cardiovascular risk, MAOI/SSRI interactions, and psychiatric history
  • Long-duration session scheduling with shift-aware dyad/sitter staffing
  • Vitals monitoring (BP, HR, temperature) across the full 10–14 hour arc
  • Real-time adverse event capture (nausea, hypertension spikes, anxiety, behavioral concerns)
  • Structured session notes with AI-assisted documentation
  • Multi-week integration program with journaling, intention revisits, and care-team check-ins

Why long-duration sessions need purpose-built software

A 12-hour session crosses staff shifts, mealtimes, and multiple vitals checkpoints. Documentation written hours later loses fidelity. Extended session EHR support keeps a single, structured timeline across handoffs—so the clinician on shift at hour 11 has the full picture without scrolling through scattered notes. Dyad staffing coordination keeps facilitator pairs aligned across the day.

Safety, screening, and adverse event tracking

Mescaline's sympathomimetic profile means cardiovascular pre-screening is non-negotiable. Our pre-screening workflow flags risk patterns early, and our adverse event tracking module captures vitals trends, GI distress, and behavioral events in a structured, reportable format suitable for research protocols and regulator reporting.

Hubs: For clinics · Features · Extended session EHR · Integration workflow · Contact

Learn more about mescaline and psychedelic care

Trusted external resources

Independent research centers, directories, and clinical programs—provided for reference (Ignite Synergy is not affiliated unless explicitly stated).

Note: Mescaline is a Schedule I controlled substance under U.S. federal law outside of narrow research and religious-exemption contexts. Ignite Synergy is software infrastructure for legally operating programs—clinical research, religious-exempt practices, and clinics in jurisdictions where mescaline-assisted care is authorized.